Lobbyist Insight

Colorado · 2025-2026

HB25-B1012

Prescription Drug Benefit Information Transparency

Read HB25-B1012 at the Colorado legislature →

16 registered positions on this bill · 16 state a side.

Lobbyist or firmFor clientPositionSession
Virtual Operations, LLCAcupuncture Association of ColoradoMonitoring2025-2026
Castro, PrimoBiotechnology Innovation OrganizationOpposing2025-2026
Swan, Sarah EhrlichBristol Myers SquibbOpposing2025-2026
Emma Hudson Consulting LLCChronic Care CollaborativeOpposing2025-2026
Colorado Legislative StrategiesColorado BioScience AssociationOpposing2025-2026
Goodman, Amy BerenbaumColorado BioScience AssociationOpposing2025-2026
Bogen Public Affairs, LLCColorado Organizations Responding to AIDS/HIVOpposing2025-2026
Mizer, SusannaHealthier ColoradoOpposing2025-2026
Kibler, Kristina LLupus ColoradoOpposing2025-2026
Dubray, MeganMerck Sharp & Dohme LLC.Opposing2025-2026
Howes WolfMerck Sharpe & Dohme CorporationOpposing2025-2026
Wolf Strategies, LLCMerck Sharpe & Dohme CorporationOpposing2025-2026
Finseth, Lisbet TeskeNational Multiple Sclerosis SocietyOpposing2025-2026
BRANDEBERRY MCKENNA PUBLIC AFFAIRSPharmaceutical Research Manufacturers of America (PHRMA)Opposing2025-2026
BRANDEBERRY MCKENNA PUBLIC AFFAIRSPharmaceutical Research Manufacturers of American (PHRMA)Opposing2025-2026
Malick, DanaPharmaceutical Research and Manufacturers of America (PhRMA)Opposing2025-2026

Positions are as filed. A lobbyist may file more than once as a position changes.